BackLiminal Biosciences Overview

Liminal Biosciences Accounts Payable

Liminal Biosciences's accounts payable is $0.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00

Peer trimmed avg / median

Loading

Liminal Biosciences Accounts Payable History

Loading

Liminal Biosciences vs. peers: Accounts Payable Comparison

Loading

Liminal Biosciences Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Liminal Biosciences (LMNL) FAQ

As of the most recent data (June 2023), LMNL shows a accounts payable of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LMNL's accounts payable is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Liminal Biosciences is outperforming or lagging.

Tracking LMNL's accounts payable over time shows whether Liminal Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Liminal Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $0) with ownership activity and broader fundamentals.

Liminal Biosciences's accounts payable is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.